Surgery Partners is trading 5.47% down at $13.13 in after-hours trading, with no new company-specific announcement or filing explaining the August 31, 2026 after-hours decline.
- Its latest identifiable company news remains the August 10 second-quarter report.
- The report showed $848.9 million in revenue, a $15.0 million net loss, and reaffirmed 2026 guidance.
- Broader markets finished lower as geopolitical and interest-rate concerns weighed on sentiment, but they do not clearly explain the company-specific drop.